Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adva Mechaly

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Analytical and Bioanalytical Chemistry|March 26, 2021
Spike vs nucleocapsid SARS-CoV-2 antigen detection: application in nasopharyngeal swab specimensMoria Barlev-Gross, Shay Weiss, Amir Ben-Shmuel, et al.
Nature Communications|February 12, 2021
Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibodyRonit Rosenfeld, Tal Noy-Porat, Adva Mechaly, et al.
Nature Communications|August 29, 2020
A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopesTal Noy-Porat, Efi Makdasi, Ron Alcalay, et al.
Vaccines|February 26, 2022
Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human SeraYfat Yahalom-Ronen, Noam Erez, Morly Fisher, et al.
Archives of Toxicology|May 16, 2022
rVSV-ΔG-SARS-CoV-2-S vaccine: repeated intramuscular (IM) toxicity, local tolerance, immunogenicity and biodistribution study in NZW rabbitsAmir Rosner, Michal Steiner, Sharon Melamed, et al.
Iscience|May 3, 2021
Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 miceTal Noy-Porat, Adva Mechaly, Yinon Levy, et al.
Cell Reports|August 31, 2021
The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against viral variantsEfi Makdasi, Anat Zvi, Ron Alcalay, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Analytical and Bioanalytical Chemistry|March 26, 2021
Spike vs nucleocapsid SARS-CoV-2 antigen detection: application in nasopharyngeal swab specimensMoria Barlev-Gross, Shay Weiss, Amir Ben-Shmuel, et al.
Nature Communications|February 12, 2021
Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibodyRonit Rosenfeld, Tal Noy-Porat, Adva Mechaly, et al.
Nature Communications|August 29, 2020
A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopesTal Noy-Porat, Efi Makdasi, Ron Alcalay, et al.
Vaccines|February 26, 2022
Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human SeraYfat Yahalom-Ronen, Noam Erez, Morly Fisher, et al.
Archives of Toxicology|May 16, 2022
rVSV-ΔG-SARS-CoV-2-S vaccine: repeated intramuscular (IM) toxicity, local tolerance, immunogenicity and biodistribution study in NZW rabbitsAmir Rosner, Michal Steiner, Sharon Melamed, et al.
Iscience|May 3, 2021
Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 miceTal Noy-Porat, Adva Mechaly, Yinon Levy, et al.
Cell Reports|August 31, 2021
The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against viral variantsEfi Makdasi, Anat Zvi, Ron Alcalay, et al.
Pageof 4